Suppr超能文献

非妊娠成年人亚临床甲状腺功能障碍的筛查:美国预防服务工作组的证据总结

Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force.

作者信息

Helfand Mark

机构信息

Oregon Health & Science University, Evidence-based Practice Center, Portland, Oregon 97239, USA.

出版信息

Ann Intern Med. 2004 Jan 20;140(2):128-41. doi: 10.7326/0003-4819-140-2-200401200-00015.

Abstract

BACKGROUND

Subclinical thyroid dysfunction is a risk factor for developing symptomatic thyroid disease. Advocates of screening argue that early treatment can prevent serious morbidity in individuals who are found to have laboratory evidence of subclinical thyroid dysfunction.

PURPOSE

This article focuses on whether it is useful to order a thyroid function test for patients who have no history of thyroid disease and have few or no signs or symptoms of thyroid dysfunction.

DATA SOURCES

A MEDLINE search, supplemented by searches of EMBASE and the Cochrane Library, reference lists, and a local database of thyroid-related articles.

STUDY SELECTION

Controlled treatment studies that used thyroid-stimulating hormone (TSH) levels as an inclusion criterion and reported quality of life, symptoms, or lipid level outcomes were selected. Observational studies of the prevalence, progression, and consequences of subclinical thyroid dysfunction were also reviewed.

DATA EXTRACTION

The quality of each trial was assessed by using preset criteria, and information about setting, patients, interventions, and outcomes was abstracted.

DATA SYNTHESIS

The prevalence of unsuspected thyroid disease is lowest in men and highest in older women. Evidence regarding the efficacy of treatment in patients found by screening to have subclinical thyroid dysfunction is inconclusive. No trials of treatment of subclinical hyperthyroidism have been done. Several small, randomized trials of treatment of subclinical hypothyroidism have been done, but the results are inconclusive except in patients who have a history of treatment of Graves disease, a subgroup that is not a target of screening in the general population. Data on the adverse effects of broader use of L-thyroxine are sparse.

CONCLUSION

It is uncertain whether treatment will improve quality of life in otherwise healthy patients who have abnormal TSH levels and normal free thyroxine levels.

摘要

背景

亚临床甲状腺功能障碍是发生有症状甲状腺疾病的一个危险因素。筛查的支持者认为,早期治疗可预防那些经实验室检查证实有亚临床甲状腺功能障碍的个体出现严重发病情况。

目的

本文重点探讨对于无甲状腺疾病史且几乎没有或没有甲状腺功能障碍体征或症状的患者,进行甲状腺功能检查是否有用。

数据来源

通过检索MEDLINE,并辅以EMBASE和Cochrane图书馆、参考文献列表以及一个甲状腺相关文章的本地数据库进行检索。

研究选择

选取以促甲状腺激素(TSH)水平作为纳入标准并报告生活质量、症状或血脂水平结果的对照治疗研究。还对亚临床甲状腺功能障碍的患病率、进展及后果的观察性研究进行了综述。

数据提取

使用预设标准评估每个试验的质量,并提取有关研究背景、患者、干预措施和结果的信息。

数据综合

未被怀疑的甲状腺疾病患病率在男性中最低,在老年女性中最高。关于对筛查发现有亚临床甲状腺功能障碍的患者进行治疗的疗效证据尚无定论。尚未进行亚临床甲状腺功能亢进治疗的试验。已开展了几项亚临床甲状腺功能减退治疗的小型随机试验,但结果尚无定论,除了那些有格雷夫斯病治疗史的患者,而这一亚组人群并非普通人群筛查的目标对象。关于更广泛使用左甲状腺素的不良反应的数据很少。

结论

对于促甲状腺激素水平异常但游离甲状腺素水平正常的健康患者,治疗是否能改善其生活质量尚不确定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验